Literature DB >> 15166380

A family with severe insulin resistance and diabetes due to a mutation in AKT2.

Stella George1, Justin J Rochford, Christian Wolfrum, Sarah L Gray, Sven Schinner, Jenny C Wilson, Maria A Soos, Peter R Murgatroyd, Rachel M Williams, Carlo L Acerini, David B Dunger, David Barford, A Margot Umpleby, Nicholas J Wareham, Huw Alban Davies, Alan J Schafer, Markus Stoffel, Stephen O'Rahilly, Inês Barroso.   

Abstract

Inherited defects in signaling pathways downstream of the insulin receptor have long been suggested to contribute to human type 2 diabetes mellitus. Here we describe a mutation in the gene encoding the protein kinase AKT2/PKBbeta in a family that shows autosomal dominant inheritance of severe insulin resistance and diabetes mellitus. Expression of the mutant kinase in cultured cells disrupted insulin signaling to metabolic end points and inhibited the function of coexpressed, wild-type AKT. These findings demonstrate the central importance of AKT signaling to insulin sensitivity in humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166380      PMCID: PMC2258004          DOI: 10.1126/science.1096706

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  18 in total

Review 1.  Transcriptional control of adipogenesis.

Authors:  S M Rangwala; M A Lazar
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

Review 2.  Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes.

Authors:  M I McCarthy; A T Hattersley
Journal:  Expert Rev Mol Diagn       Date:  2001-11       Impact factor: 5.225

3.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

4.  Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency.

Authors:  M Vihinen; A Villa; P Mella; R F Schumacher; G Savoldi; J J O'Shea; F Candotti; L D Notarangelo
Journal:  Clin Immunol       Date:  2000-08       Impact factor: 3.969

Review 5.  The genetics of type 2 diabetes.

Authors:  A L Gloyn; M I McCarthy
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2001-09       Impact factor: 4.690

6.  Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP.

Authors:  Jing Yang; Peter Cron; Valerie M Good; Vivienne Thompson; Brian A Hemmings; David Barford
Journal:  Nat Struct Biol       Date:  2002-12

Review 7.  Genetics of insulin resistance.

Authors:  O Pedersen
Journal:  Exp Clin Endocrinol Diabetes       Date:  1999       Impact factor: 2.949

8.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

Review 9.  The PI3K-PDK1 connection: more than just a road to PKB.

Authors:  B Vanhaesebroeck; D R Alessi
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

Review 10.  Ten years of protein kinase B signalling: a hard Akt to follow.

Authors:  D P Brazil; B A Hemmings
Journal:  Trends Biochem Sci       Date:  2001-11       Impact factor: 13.807

View more
  196 in total

1.  Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.

Authors:  Kebin Zhang; Ling Li; Yajuan Qi; Xiaoping Zhu; Boyi Gan; Ronald A DePinho; Travis Averitt; Shaodong Guo
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

2.  Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle.

Authors:  Revati Wani; N Sharmila Bharathi; Jeffrey Field; Allen W Tsang; Cristina M Furdui
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

3.  Regulation of insulin signaling by the phosphatidylinositol 3,4,5-triphosphate phosphatase SKIP through the scaffolding function of Pak1.

Authors:  Takeshi Ijuin; Tadaomi Takenawa
Journal:  Mol Cell Biol       Date:  2012-07-02       Impact factor: 4.272

4.  Akt-dependent Skp2 mRNA translation is required for exiting contact inhibition, oncogenesis, and adipogenesis.

Authors:  Veronique Nogueira; Deepa Sundararajan; Jennifer M Kwan; Xiao-ding Peng; Neha Sarvepalli; Nahum Sonenberg; Nissim Hay
Journal:  EMBO J       Date:  2012-02-03       Impact factor: 11.598

Review 5.  Lipodystrophy: pathophysiology and advances in treatment.

Authors:  Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

6.  Akt2 deficiency promotes cardiac induction of Rab4a and myocardial β-adrenergic hypersensitivity.

Authors:  Sharon Etzion; Yoram Etzion; Brian DeBosch; Peter A Crawford; Anthony J Muslin
Journal:  J Mol Cell Cardiol       Date:  2010-08-20       Impact factor: 5.000

Review 7.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

8.  Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.

Authors:  Christine Kurlawalla-Martinez; Bangyan Stiles; Ying Wang; Sherin U Devaskar; Barbara B Kahn; Hong Wu
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 9.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

10.  Sequential cleavage of insulin receptor by calpain 2 and γ-secretase impairs insulin signalling.

Authors:  Tomoyuki Yuasa; Kikuko Amo-Shiinoki; Shuhei Ishikura; Mitsuyoshi Takahara; Takaaki Matsuoka; Hideaki Kaneto; Akio Kuroda; Munehide Matsuhisa; Seiichi Hashida
Journal:  Diabetologia       Date:  2016-09-30       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.